Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
Details for 2020163993
Up to date per 15.06.2026
Actions
Details for 2020163993
Title / Product Name
KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2020163993
EP Publication Number
3725810
E-Number
1502838
Language
EN
PCT Number
Publication Date
21.10.2020 A
06.07.2022 B1
Registration Date
06.07.2022
AT Publication Date
15.07.2022
Application Date
21.05.2013
Registration Number
-
Priorities
23.05.2012
WO
PCT/EP2012/002211
IPC
C07K 16/30 20060101AFI20200917BHEP
Maximum Duration of Protection
21.05.2033
Owner
Astellas Pharma Inc. 5-1, Nihonbashi-honcho 2-chome, Chuo-ku Tokyo 103-8411JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHFreiligrathstrasse 12 55131 MainzDE
Representative
Representative
Dipl.-Ing. Mag. Michael BabelukFlorianigasse 26/31080 WienAT